Heart Test Valuation
| HSCSW Stock | USD 0.04 0.01 19.24% |
Heart Test seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Heart Test Laboratories from evaluating the firm fundamentals such as return on asset of -0.63, and Return On Equity of -1.63 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Heart Test's price fluctuation is out of control at this time. Calculation of the real value of Heart Test Laboratories is based on 3 months time horizon. Increasing Heart Test's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heart stock is determined by what a typical buyer is willing to pay for full or partial control of Heart Test Laboratories. Since Heart Test is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heart Stock. However, Heart Test's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0403 | Real 0.0294 | Hype 0.04 |
The intrinsic value of Heart Test's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heart Test's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heart Test Laboratories helps investors to forecast how Heart stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heart Test more accurately as focusing exclusively on Heart Test's fundamentals will not take into account other important factors: Heart Test Total Value Analysis
Heart Test Laboratories is currently projected to have takeover price of 0 with market capitalization of 0, debt of 1.04 M, and cash on hands of 723.48 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Heart Test fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 1.04 M | 723.48 K |
Heart Test Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Heart Test has an asset utilization ratio of 0.2 percent. This indicates that the Company is making $0.001957 for each dollar of assets. An increasing asset utilization means that Heart Test Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Heart Test Profitability Analysis
The company reported the revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 0.About Heart Test Valuation
Our relative valuation model uses a comparative analysis of Heart Test. We calculate exposure to Heart Test's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heart Test's related companies.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange.
Heart Test Growth Indicators
Investing in growth stocks can be very risky. If the company such as Heart Test does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 352.5 K |
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.